Canada markets closed

Nemaura Medical Inc. (NMRD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0542-0.0025 (-4.39%)
At close: 01:27PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.57M
Enterprise Value 21.07M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)712.42
Price/Book (mrq)N/A
Enterprise Value/Revenue 7.18k
Enterprise Value/EBITDA -4.68

Trading Information

Stock Price History

Beta (5Y Monthly) -0.06
52-Week Change 3-92.78%
S&P500 52-Week Change 322.36%
52 Week High 31.2500
52 Week Low 30.0525
50-Day Moving Average 30.0801
200-Day Moving Average 30.2911

Share Statistics

Avg Vol (3 month) 338.15k
Avg Vol (10 day) 341.35k
Shares Outstanding 528.9M
Implied Shares Outstanding 628.9M
Float 818.83M
% Held by Insiders 148.62%
% Held by Institutions 14.41%
Shares Short (Dec 15, 2023) 452.57k
Short Ratio (Dec 15, 2023) 40.3
Short % of Float (Dec 15, 2023) 40.31%
Short % of Shares Outstanding (Dec 15, 2023) 40.18%
Shares Short (prior month Nov 15, 2023) 4192.2k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Dec 05, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Dec 05, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-81.19%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.29M
Net Income Avi to Common (ttm)-10.65M
Diluted EPS (ttm)-0.3900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)137.42k
Total Cash Per Share (mrq)0
Total Debt (mrq)19.64M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.19
Book Value Per Share (mrq)-0.62

Cash Flow Statement

Operating Cash Flow (ttm)-9.57M
Levered Free Cash Flow (ttm)-10.07M